The stock's fall snapped a three-day winning streak.

Contract researcher Charles River Laboratories, which has been slashing costs as it faces financial headwinds, plans to ...

A global pharma company is scaling back operations in the Triangle as it closes one facility and plans to wind down ...

Charles River Laboratories International (NYSE:CRL – Free Report) had its price objective lowered by Morgan Stanley from $220.00 to $184.00 in a research report released on Wednesday morning,Benzinga ...

Charles River Laboratories International, Inc. CRL is scheduled to report fourth-quarter 2024 results on Feb.19, before ...

Flagship Harbor Advisors LLC purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) ...

Charles River is shuttering its pathology facility in Durham, North Carolina, after determining the site “is not a strategic ...

This was the stock's second consecutive day of gains.

Read here for an analysis of Charles River's (CRL) strong financial performance with high ROE and decreasing liabilities, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Morgan Stanley analyst Tejas Savant lowered the firm’s price target on Charles River (CRL) to $184 from $220 and keeps an Equal Weight rating ...